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Abstract: There have been a few studies that examined the oxidative stress effects of nicotine during pregnancy and 
lactation. The adverse effect of prenatal smoking exposure on human fetal development and growth has been a major 
public health issue. Active or passive smoking during pregnancy can result in a wide variety of adverse outcomes, 
including intrauterine growth retardation (IUGR), prematurity, stillbirth, and the sudden infant death syndrome. Smoking 
in pregnancy has also been associated with an increased risk of attention deficit and learning problems in childhood. Some 
studies argued that as a principal component of tobacco smoke, nicotine alone is responsible for the majority of negative 
reproductive outcomes. Nicotine and its major metabolite cotinine can cross the placental barrier. The level of nicotine in 
fetal tissues was found to be equal to or greater than the plasma nicotine level in the mothers. The oxidative stress induce 
by nicotine has been increasingly postulated as a major contributor to endothelial dysfunction. A large body of research 
has investigated the potential role of antioxidant nutrients in the prevention of endothelial dysfunction in women. 
Therefore, the present study was undertaken to assess the potential benefit of antioxidant supplementation on markers of 
placental oxidative stress in an in vitro model of endothelial dysfunction induced by nicotine, since it was previously 
found that nicotine is able to trigger the placental secretion of stress molecules. In this regard, we evaluated the effects of 
vitamin C, vitamin E and N-acetylcysteine (NAC), alone or in combination, in placental villi culture after exposure to 
nicotine. The effect of antioxidant nutrients on trophoblast cells proliferation and vitality was also evaluated. The results 
obtained suggest that in a patho-physiological condition, such as endothelial dysfunction induced by nicotine, the 
deleterious effect of reactive oxygen species may be counteracted by an antioxidant therapy, and there is the need to 
investigate the optimum dosing and timing of antioxidants administration, since an inappropriate antioxidant treatment in 
pregnant women may have deleterious consequences, reducing placental cells proliferation until to cell death. 
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INTRODUCTION 
  Preeclampsia (PE) is a human pregnancy-specific 
disorder that adversely affects maternal vascular function 
and fetal intrauterine growth, and is the leading cause of 
maternal and perinatal mortality in developed countries [1]. 
A potential role for oxidative stress in the pathophysiology 
of PE emerged in the last years [2-4]. Synthesis of free 
radicals by a dysfunctional placenta and endothelium seems 
to play a central role in this association, since they, through 
the oxidative damage of biomolecules and lipid peroxidation, 
contribute to the systemic endothelial cell dysfunction and 
activation accounting for the clinical expression of the 
disease [5, 6]. 
  On this basis, antioxidants such as vitamin C and vitamin 
E have been proposed as potential therapeutic or 
prophylactic treatment for PE [6]. Accordingly, Chappell et 
al. [7] in a randomised trial of 283 women at high risk for 
PE, showed a reduction in the incidence of the disease in  
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women treated with vitamin C and E from the second 
trimester of pregnancy [7]. This effect was followed by a 
diminution of the indices of oxidative stress towards values 
that were observed in a group of healthy women [8]. 
  Vitamin C and E are two essential nutrients that can 
scavenge free radicals and constitute a strong line of defence 
in retarding reactive oxygen species (ROS)-induced cellular 
damage. Indeed, vitamin E, mainly -tocopherol, is the 
major peroxyl radical scavenger in biological lipid phases, 
such as membranes. Its antioxidant action has been ascribed 
to its ability to chemically act as a lipid-based free radical 
chain-breaking molecule, thereby inhibiting lipid 
peroxidation [9]. With respect to vitamin C, it has been 
shown to scavenge free radicals directly in the aqueous 
phases of cells and circulatory system, and also to protect 
membranes and other hydrophobic compartments from 
damage by rigenerating the antioxidant form of vitamin E 
[10]. A synergistic effect between the two vitamins in vitro 
and  in vivo has been also demonstrated [9]. Indeed, the 
proposed mechanism of action was that when vitamin E 
intercepts a radical thus forming a complex -tocopheroxyl-
radical which can be reduced back to -tocopherol by 
vitamin C or other reducing agents, thus attenuating the 78    The Open Biochemistry Journal, 2010, Volume 4  Gallo et al. 
propagation of free radical reactions [11, 12]. Thus vitamin 
C prevents the prooxidant activity of vitamin E by 
decreasing the activity of tocopheroxyl radical to -
tocopherol, thereby contributing to increased total 
antioxidant status and reducing oxidative stress [13]. With 
respect to oxidative stress and PE, previous studies showed 
that prenatal nicotine exposure resulted in inhibition of fetal 
growth, also, nicotine in the maternal placenta may be 
involved with the observed increase in oxidative stress and 
lipid peroxidation. The above effects of nicotine on the 
maternal placenta may also contribute to an increased 
susceptibility of the fetus to environmental toxinsin [14].  
  Also, the adverse effect of prenatal smoking exposure on 
human fetal development and growth has been a major 
public health issue. Active or passive smoking during 
pregnancy can result in a wide variety of adverse outcomes, 
including intrauterine growth retardation (IUGR), 
prematurity, stillbirth, and the sudden infant death syndrome. 
Smoking in pregnancy has also been associated with an 
increased risk of attention deficit and learning problems in 
childhood [1-3]. Some studies argued that as a principal 
component of tobacco smoke, nicotine alone is responsible 
for the majority of negative reproductive outcomes. Nicotine 
and its major metabolite cotinine can cross the placental 
barrier. The level of nicotine in fetal tissues was found to be 
equal to or greater than the plasma nicotine level in the 
mothers [1-3]. The oxidative stress induced by nicotine has 
been increasingly postulated as a major contributor to 
endothelial dysfunction [15-20].  
  There have been a few studies that examined the 
oxidative stress effects of nicotine during pregnancy and 
lactation. Therefore, the present study was primarly designed 
to assess the potential benefit of antioxidant supplementation 
on markers of placental oxidative stress [malondialdehyde 
(MDA), and glutathione (GSH)] induced by nicotine, as well 
as its effect on trophoblast cells proliferation and vitality. In 
this regard, we evaluated the effects of vitamin C and E 
alone or in combination, but also those of N-acetylcysteine 
(NAC), the acetylated variant of the amino acid L-cysteine, 
that is known to stimulate GSH synthesis, to promote 
detoxification and to act directly as free radical scavenger.  
MATERIALS AND METHODS 
Placental Explants Culture 
  Placentae were obtained under sterile conditions from 
normal pregnancies undergoing elective caesarean section at 
term. Maternal consent was obtained according to the 
guidelines of Ethics Committee. Chunks of placental 
cotyledons weighing approximately 30 g were thoroughly 
rinsed in calcium- and magnesium-free Hanks’ solution 
(HBSS), villous tissue was identified and isolated from 
membranes, large vessels, decidua and connective tissue 
under a dissection microscope. Small clusters of placental 
villi (50 mg/wet weight) were placed in a 24-well plastic 
plates and cultured in Ham’s F10 medium supplemented 
with 10% FBS, 2 mmol/L L-glutamine, 100 IU/ml penicillin, 
and 100 μg/ml streptomycin at 37°C under 5% CO2-95% air. 
Culture medium was enriched with vitamin C or vitamin E 
or NAC, alone or in combination, at concentration of 5 pM. 
Culture medium was removed after two days of culture and 
the explants were treated with different concentrations of 
Nicotine (0-100 pg/ml), dissolved in fresh Ham’s F10 
medium, enriched with antioxidants, for 6 h. Indeed, we 
have shown previously that placental villi exposed to 
different nicotine concentrations displayed a significant 
dose-dependent decrease of GSH and a significant dose 
dependent increase of MDA after 6 h of treatment (14). 
Therefore, to investigate whether vitamin C, vitamin E and 
NAC blocks the oxidative stress condition triggered by 
nicotine, we measured their influence on GSH and MDA 
content in placental villi after 6 h of ET-1 treatment.  
  Experiments were performed at least six times, using a 
single placenta for each one. 
Measurement of GSH and LPOs 
  For GSH measurement, placental tissues were 
homogenized using Mixer Mill MM 300 (QIAGEN, Milan, 
Italy) in EDTA-K
+ phosphate buffer (pH 7.4) and 10% (w/v) 
metaphosphoric acid (1:1) at 4
oC, centrifuged at 2000 g for 
10 min and the supernatants were stored at –80°C until the 
assay. GSH was measured by using a colorimetric assay kit 
(Cayman-Cayman Chemical Company, USA). 
  LPOs content was measured by the stable metabolite 
MDA with a HPLC assay as previously described (21). 
Placental explants were homogenized in mixture (1:1) of 
0,04 mol/L TRIS-HCl buffer (pH 7.4) and a solution of 
acetonitrile containing 0,1% butyl hydroxytoluene (4
oC), to 
prevent the artificial oxidation of polyunsaturated free fatty 
acid during the assay, and centrifuged at 3000 g for 15 min 
at 4°C. Supernatants were stored at –80°C until the assay.  
JEG-3 Choriocarcinoma Cells Culture 
  JEG-3 cells were obtained from the American Type 
Culture Collection (ATCC, Rockville, MD; passage number 
125), and were used within seven passages. JEG-3 cells were 
maintained routinely in RPMI medium supplemented with 
10% FBS, 2 mmol/L L-glutamine, 100 IU/ml penicillin, and 
100 μg/ml streptomycin at 37°C under 5% CO2-95% air. 
Effect of Antioxidants on JEG-3 Cells Proliferation After 
ET-1 Treatment 
  JEG-3 cells were plated at a density of 5 x 10
3 cells/well 
in 96-well plastic plates and were allowed to adhere to the 
wells overnight, then the cells were treated with different 
concentrations of the nicotine (0-100 pg/ml) in RPMI 
medium enriched with vitamin C, vitamin E and NAC alone 
or in combination. After 24 h, JEG-3 vitality and 
proliferation rate were determined with (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromides 
(MTT) assay. MTT stock solution (5 mg/ml) was added to 
each well being assayed to equal one tenth the original 
culture volume and incubated for 4 h. At the end of the 
incubation period converted dye was solubilized with acidic 
isopropanol (0,04-0,1 N HCl in absolute isopropanol). 
Absorbance of converted dye was measured at a wavelength 
of 570 nm with background subtraction at 630 nm. 
Antiproliferative Activity of Vitamin C and E and NAC 
on JEG-3 Cells 
  JEG-3 cells were plated at a density of 5 x 10
3 cells/well 
in 96-well plastic plates and were allowed to adhere to the 
wells overnight, then the cells were treated with different Potential Therapeutic Effects of Vitamin E and C  The Open Biochemistry Journal, 2010, Volume 4    79 
concentrations (5x10
-12 – 5x10
-8 M) of vitamin C, vitamin E 
and NAC for 24h. JEG-3 proliferation were determined by 
MTT assay, like described above.  
Statistical Analysis 
  Explants data were expressed as nmol/mg prot for GSH, 
and as nmol/gr tissue for MDA. JEG-3 data were expressed 
as per cent variations respect to control (each point 
represents six experiments, performed in triplicate) to better 
evidence the differences between the various treatments with 
nicotine. The ANOVA for repeated measures test followed 
by Bonferroni post-hoc test was applied for statistical 
comparison. Differences were considered significant at a 
value of P< 0.05. 
RESULTS AND DISCUSSION 
  GSH levels in explants exposed to nicotine (20-100 
pg/ml) in presence of vitamin C 5 pM did not differ from 
those in control explants (Fig. 1A). Similar results were 
observed in presence of NAC 5 pM, except for nicotine 100 
pg/ml where it can possible to note a significant (P< 0.05) 
increase of GSH levels respect to control (Fig. 1A). 
However, when placental villi were treated with nicotine in 
presence of vitamin E 5 pM, we observed a significant 
(P<0.0001) increase of GSH content that showed a dose-
dependence respect to nicotine concentration (Fig. 1A). We 
also tested the effect of a combination of vitamin C and E, 
and NAC and vitamin E, and we found no change in GSH 
levels in the first case, but a significant (P<0.001) increase of 
GSH content depending on nicotine concentration in the 
second case (Fig. 1B).  
 Table  1 shows the % variation of MDA induced by 
nicotine (20-100 pg/ml) in the placental villi. Nicotine, after 
6 h, induced a significant increase of MDA in the placental 
villi. However, when placental explants were treated with 
nicotine in presence of vitamin C, vitamin E and NAC (5 
pM), MDA levels were totally blocked (Table 1). 
      A         B  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Influence of vitamin C, vitamin E and NAC, alone (A) or in combination (B), on GSH levels in placental villi exposed for 6 h to 
different concentration of nicotine (*P<0.05; **P<0.01). 
Table1.  The Effect of Nicotine Alone (20-100 pg/ml) and in Presence of Vitamin C, Vitamin E and NAC (5pM) on MDA Level in 
the Placental Villi 
Nicotine Administration 
(6h) 
MDA Levels Nicotine 
Alone 
(% of control) 
MDA Levels  
Nicotine+Vitamin C 
(% of control) 
MDA Levels  
Nicotine+Vitamin E 
(% of control) 
MDA Levels 
Nicotine+NAC 
(% of control) 
Control 
Nicotine 0 pg/ml 
100 100 100  100 
Nicotine 
20 pg/ml 
 113+31 114+21 105+10 101+11 
Nicotine 
 50 pg/ml 
130+12* 103+12
§§ 105+11
§§ 102+10
§§ 
Nicotine 
100 pg/ml 
 207+26** 110+21
§§ 107+10
§§ 101+11
§§ 
Results are expressed as mean+S.E.M.. *P<0.05: **P<00.1 was accepted as indicative of significant difference between groups (nicotine vs control, n=5). 
§§P<00.1 
(nicotine+vitamins vs nicotine alone). 80    The Open Biochemistry Journal, 2010, Volume 4  Gallo et al. 
  The experiments performed to evaluate the influence of 
the vitamin C, vitamin E and NAC on cell vitality and 
proliferation after 24 h of nicotine treatment showed that 
nicotine significantly (P<0·001) and dose-dependently 
decreased the proliferation rate of the JEG-3 cells (Fig. 2A). 
On the contrary, vitamin C, vitamin E and NAC blocked 
totally the inhibitory effect of nicotine (Fig. 2A). 
  Finally, the combination of two antioxidants (vitamin C 
plus vitamin E or NAC plus vitamin E) were used in 
combination also blocked the inhibitory effect of nicotine on 
cells proliferation (Fig. 2B). 
  We also tested the effect of the increasing concentrations 
(5x10
-12 – 5x10
-8 M) of vitamin C, vitamin E and NAC on 
JEG-3 cells proliferation. Vitamin C showed a marked 
antiproliferative effect, achieving an inhibition of cell growth 
until to 70% at higher doses. The effect of the NAC and the 
vitamin E was more moderate respect to the vitamin C and 
the maximum inhibition was of the 27% (Fig. 3).  
 
 
 
 
 
 
 
 
 
 
Fig. (3). Antiproliferative effect in JEG-3 cells exposed to 
increasing concentrations of vitamin C, vitamin E and NAC. Cell 
proliferation was estimated after 24 h by MTT method. Results are 
expressed as mean ± SD of six experiments, each one performed in 
triplicate. * P < 0.05; ** P < 0.01. 
 
  The present study was designed to value the hypothesis 
that well known antioxidants, such as vitamin C, vitamin E 
and NAC, may lead to an improvement in the oxidative 
stress, since endothelial and placental dysfunction from 
oxidative stress [5-6]. As consequence, antioxidants have 
been proposed as a potentially advantageous prophylactic 
measure for endothelial and placental dysfunction [2-4], 
since treatment with vitamin E and C have been reported to 
reduce the incidence of endothelial and placental dysfunction 
in women and to decrease the biochemical indices of 
oxidative stress [8]. Moreover, in patients with severe 
endothelial and placental dysfunction plasma -tocopherol 
was significantly decreased compare with controls, which is 
thought to be caused by the fact that antioxidants may be 
utilized to a greater extent to counteract free radical-
mediated cell disturbances, resulting in a reduction in their 
plasma levels [11, 12]. 
  In the present study we used an in vitro model to assess 
the effect vitamin C, vitamin E and NAC on oxidative stress 
by nicotine, since previous studies showed that prenatal 
nicotine exposure resulted in inhibition of fetal growth, also, 
nicotine in the maternal placenta may be involved with the 
observed increase in oxidative stress and lipid peroxidation 
thus increasing susceptibility of the fetus to environmental 
toxins [14-20].  
  Briefly, we found that supplementation with vitamin C, 
vitamin E and NAC, alone or in combination, prevented the 
nicotine-1-induced decrease of GSH, an antioxidant 
molecule that protects cells from reactive oxygen species 
[21], as well as the nicotine-induced secretion of MDA, an 
oxidative stress molecole that plays a central role in 
oxidative damage, since it has toxic effect on cells by 
disorganizing oxidative phosphorilation in mitochondria and 
by reacting with proteins and DNA bars [22-27]. 
  Vitamin C is a potent scavenger of superoxide radicals 
and may thus have helped to maintain intracellular GSH 
concentration, in fact no changes were observed in total 
content of tripeptide GSH in placental villi exposed to 
nicotine in presence of vitamin C. On the contrary, we 
observed an increasing of GSH content when placental villi 
were exposed to nicotine in presence of vitamin E and NAC. 
We can explain this as an adaptive response to elevated 
levels of oxidizing species that elicit a specific compensatory 
      A         B  
 
 
 
 
 
 
 
 
 
 
Fig. (2). Proliferation in JEG-3 cells. Placental cells were exposed to nicotine in absence of antioxidant nutrient and in presence of vitamin C, 
vitamin E and NAC, alone (A) or in combination (B). Cell growh was estimated after 24 h by MTT method. Results are expressed as mean ± 
SD of six experiments, each one performed in triplicate. ** P< 0.01. Potential Therapeutic Effects of Vitamin E and C  The Open Biochemistry Journal, 2010, Volume 4    81 
increase in antioxidant molecule activities. Vitamin E, in 
fact, is the major peroxyl radical scavenger in biological 
lipid phases such as membranes. Its antioxidant action has 
been ascribed to its ability to chemically act as a lipid-based 
free radical chain-breaking molecule, thereby inhibiting lipid 
peroxidation and protecting the organism against oxidative 
damage. Indeed, the interaction between vitamins C and E in 
the antioxidant defense of biochemical systems is well 
established because vitamin C can reduce tocopheroxyl 
radicals directly or indirectly and thus support the 
antioxidant activity of vitamin E. Upon oxidation these 
micronutrients need to be regenerated in the biological 
setting, hence the need for further coupling to nonradical 
reducing systems such as GSH. Because the metabolism of 
the reactive species should be regulated selectively at or near 
the sites of their generation, increases in the expression of 
these reducing systems in preeclamptic placentas would act 
as a protective mechanism by which placental cells minimize 
tissutal oxidative damage. Same conclusions we can 
hypothesize for NAC, used both as a precursor in the 
synthesis of GSH and as a direct radical scavenger. Indeed, 
our results shows an inhibition of the MDA production, one 
of the most markers of secondary end products of lipid 
peroxidation, supporting the evidence of the protective effect 
of vitamin supplementation in placental villi exposed to 
nicotine since the process of lipid peroxidation of 
membranes has been implicated as one of the primary events 
in oxidative cellular damage and has been shown to be 
associated with fine structure disturbance and subsequent 
function loss of biological membranes. The second important 
result of this study is the opposite effect of the antioxidant 
substances on basic cell physiological process. Indeed, 
vitamin C, vitamin E and NAC improved cell survival when 
JEG-3 cells were exposed to nicotine, but increasing 
concentrations of these nutrients were able to induce cell 
death and to block cell proliferation when JEG-3 were 
maintained in culture without nicotine.  
CONCLUSIONS 
  In conclusion, vitamin C, vitamin E and NAC, alone or in 
combination, protect the human placenta against the 
deleterious effects of reactive oxygen species induced by 
nicotine, and further support the linkage between nicotine 
and reactive oxygen species, and a likely explanation of their 
effect is through this mechanism. These data would support 
the hypothesis that nicotine would induce an initial free 
radicals overgeneration, promptly scavenged by 
supplementation with vitamin C and E, therefore reinforcing 
placental resistance to oxidative injury. 
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